VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 1 filers reported holding VALEANT PHARMACEUTICALS INTL in Q2 2022. The put-call ratio across all filers is - and the average weighting 2.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $283,000 | -19.6% | 12,386 | -2.9% | 0.10% | -16.8% |
| Q4 2021 | $352,000 | -0.8% | 12,750 | 0.0% | 0.12% | -7.8% |
| Q3 2021 | $355,000 | -5.1% | 12,750 | 0.0% | 0.13% | -6.5% |
| Q2 2021 | $374,000 | -7.7% | 12,750 | 0.0% | 0.14% | -13.2% |
| Q1 2021 | $405,000 | +52.8% | 12,750 | 0.0% | 0.16% | +39.5% |
| Q4 2020 | $265,000 | +33.8% | 12,750 | 0.0% | 0.11% | +17.5% |
| Q3 2020 | $198,000 | -15.0% | 12,750 | 0.0% | 0.10% | -20.5% |
| Q2 2020 | $233,000 | +17.7% | 12,750 | 0.0% | 0.12% | +5.2% |
| Q1 2020 | $198,000 | -48.0% | 12,750 | 0.0% | 0.12% | -35.2% |
| Q4 2019 | $381,000 | +36.6% | 12,750 | 0.0% | 0.18% | +26.1% |
| Q3 2019 | $279,000 | -13.4% | 12,750 | 0.0% | 0.14% | -14.5% |
| Q2 2019 | $322,000 | +2.2% | 12,750 | 0.0% | 0.17% | -2.9% |
| Q1 2019 | $315,000 | +62.4% | 12,750 | +21.4% | 0.17% | +41.3% |
| Q4 2018 | $194,000 | -28.1% | 10,500 | 0.0% | 0.12% | -22.4% |
| Q3 2018 | $270,000 | +10.7% | 10,500 | 0.0% | 0.16% | +3.3% |
| Q2 2018 | $244,000 | +46.1% | 10,500 | 0.0% | 0.15% | +48.0% |
| Q1 2018 | $167,000 | -23.4% | 10,500 | 0.0% | 0.10% | -23.3% |
| Q4 2017 | $218,000 | +45.3% | 10,500 | 0.0% | 0.13% | +38.5% |
| Q3 2017 | $150,000 | -33.3% | 10,500 | -19.2% | 0.10% | -37.3% |
| Q2 2017 | $225,000 | +57.3% | 13,000 | 0.0% | 0.15% | +48.5% |
| Q1 2017 | $143,000 | +16.3% | 13,000 | +52.9% | 0.10% | +9.6% |
| Q4 2016 | $123,000 | – | 8,500 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bruce & Co., Inc. | 850,000 | $6,987,000 | 2.38% |